SIBN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SI-BONE Inc (SIBN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock's strong analyst ratings, hedge fund buying, and its position in a high-growth sector with improving profitability make it a solid choice. While recent financials show some challenges, the company's revenue growth and premium valuation potential outweigh the negatives.
The MACD is positive at 0.227, indicating bullish momentum, though it is contracting. RSI at 50.088 is neutral, showing no overbought or oversold conditions. Moving averages are converging, suggesting a potential breakout. Key support is at 12.678, and resistance is at 14.572, with the current pre-market price at 13.67 near the pivot level of 13.625.
Hedge fund buying has surged by 457520.97% over the last quarter.
Analysts maintain a Buy rating with price targets ranging from $20 to $24, citing strong top-line growth, improving profitability, and a unique business model.
The company has multiple growth catalysts, including a new product cycle.
Financial performance in Q4 2025 showed a decline in net income (-63.43% YoY) and EPS (-63.64% YoY).
Gross margin slightly dropped to 79.03%.
In Q4 2025, revenue increased by 14.99% YoY to $56.35M, but net income dropped to -$1.64M (-63.43% YoY), and EPS fell to -0.04 (-63.64% YoY). Gross margin slightly declined to 79.03%.
Analysts are bullish, with multiple Buy ratings and price targets ranging from $20 to $24. Analysts highlight the company's faster top-line growth, improving profitability, and unique position in the musculoskeletal market.
